ZA735221B - Improved dosage regimen - Google Patents

Improved dosage regimen

Info

Publication number
ZA735221B
ZA735221B ZA735221A ZA735221A ZA735221B ZA 735221 B ZA735221 B ZA 735221B ZA 735221 A ZA735221 A ZA 735221A ZA 735221 A ZA735221 A ZA 735221A ZA 735221 B ZA735221 B ZA 735221B
Authority
ZA
South Africa
Prior art keywords
dosage regimen
improved dosage
improved
regimen
dosage
Prior art date
Application number
ZA735221A
Other languages
English (en)
Inventor
H Johnson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA735221B publication Critical patent/ZA735221B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA735221A 1972-08-07 1973-07-31 Improved dosage regimen ZA735221B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27829272A 1972-08-07 1972-08-07

Publications (1)

Publication Number Publication Date
ZA735221B true ZA735221B (en) 1974-07-31

Family

ID=23064436

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA735221A ZA735221B (en) 1972-08-07 1973-07-31 Improved dosage regimen

Country Status (6)

Country Link
US (1) US4064248A (xx)
AU (1) AU5884473A (xx)
BE (1) BE803325A (xx)
DE (1) DE2339893A1 (xx)
FR (1) FR2208656B1 (xx)
ZA (1) ZA735221B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096271A (en) * 1977-08-03 1978-06-20 American Cyanamid Company Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
US6727278B1 (en) * 1986-08-27 2004-04-27 Dms Pharmaceutical Inc. Pharmaceutically active agents that impede amyloid formation in vivo
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
AU763945B2 (en) * 1999-06-04 2003-08-07 Skyepharma Inc. Oil-core compositions for the sustained release of hydrophobic drugs
US20040213837A1 (en) * 2002-08-05 2004-10-28 Sankaram Mantripragada Oil-core compositions for the sustained release of hydrophobic drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1147760A (en) * 1965-06-17 1969-04-10 Sterling Drug Inc Heterocyclic nitrogen compounds
IE35639B1 (en) * 1970-10-05 1976-04-14 Ici Ltd Pyridoquinoline derivatives

Also Published As

Publication number Publication date
US4064248A (en) 1977-12-20
BE803325A (fr) 1974-02-07
AU5884473A (en) 1975-02-06
DE2339893A1 (de) 1974-02-21
FR2208656A1 (xx) 1974-06-28
FR2208656B1 (xx) 1977-11-10

Similar Documents

Publication Publication Date Title
JPS57133874A (en) Pipet-chip package
CS609973A2 (en) Nosic informace
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
GB1405253A (en) 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes
AU6329873A (en) Flameprofing
GB1407713A (en) 2-alkoxy-cephalosporins
AU5993373A (en) N-sulphenylated carbamidoximes
AU6362373A (en) N-propargylacetanilide herbicedes
GB1401579A (en) Indolo-quinolizines
GB1402226A (en) 3-cyanochromones
ZA735221B (en) Improved dosage regimen
GB1408010A (en) Sulphamoylphenyl-imidazolidinones
IE37400L (en) Package
AU5191873A (en) Benzylpyrimidines
GB1401735A (en) Imino-lactams
HK45678A (en) Imino-isoindolinones
AU5711073A (en) Benzenesulfonyl-ureas benzenesulfonyl-ureas
AU5233473A (en) Nitro-imidazolyl-pyrimidines
AU6332973A (en) Bulbholders
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
GB1400667A (en) 4-spirocyclopropyl-androstenes
GB1405254A (en) Bis- substituted-henoxy- propanes
ZA728553B (en) Tablets
HK10479A (en) Weatherbar
GB1402045A (en) 11-o-methanesulphonylerythromycins